As the point of care continues to shift toward home-based applications, designers must consider how clinicians and caregivers can responsibly put more care in a patient’s hands. (Credit: Pixabay/Apichit Yutithammanurak)

As the point of care continues to shift toward home-based applications, designers must consider how clinicians and caregivers can responsibly put more care in a patient’s hands. The COVID-19 pandemic has accelerated the desire to do more outside of traditional institutional centers and opened up a whole new world of ideas and options.

Technology is driving some of the change while market adoption is strong by enabling user-operated devices to achieve higher levels of acuity and reliability to perform critical functions. A panel of experts at MD&M West will talk about the shift, and how design and product development engineers can incorporate the latest design tends in these fast-growing areas. Topics include:

  • Technology-driven design trends.
  • How COVID-19 is shaping the future for home-healthcare products.
  • Enabling the at-home patient.
  • Achieving robust authentication of procedural compliance by hybridizing devices with consumer technology.

On the Panel

Philip Remedios, Principal, Director of Design & Development BlackHagen Design

Philip’s design and engineering background spans three continents, over 25 years in research and product development, and a degree in Industrial Design/Transportation from California’s prestigious Art Center College of Design. Before transitioning into product design, Philip spent 8 years as an automotive designer, initially with Volkswagen AG in Germany and then with several consulting firms in California. In 1995, Philip joined I.N. Inc., a full-service product development and manufacturing firm, as director of program management and ultimately vice president of R&D. In 2002, he joined BlackHägen Design as CFO and partner responsible for design and development.

Jennifer McCanney, Co-Executive Director UCLA Biodesign Program

Dr. Jennifer McCaney is the co-executive director of UCLA Biodesign, an early-stage innovation program for medical technology. An adjunct assistant professor at the UCLA David Geffen School of Medicine and Anderson School of Management, she is a leading expert in disruptive technology and entrepreneurship in healthcare. She is the former director of Medtech Innovator, a 501(c)3 non-profit. She launched the global platform for early-stage medical device innovation in 2015. A Fulbright Scholar, she completed her PhD in mechanical engineering at Stanford University and MS in biomedical engineering from the University of New South Wales.

Gia Rozells, Director of User Experience, Becton Dickinson

Gia is the director of user experience for Becton Dickinson where she’s implementing a new innovation process and expanding the UXD function. Gia was also an HCI pioneer who drove the integration of customer-centered thinking into the core values and processes at Intuit. She was the first director of user experience at Intuit and grew the UXD community to over 200 research and design experts. She authored the first version of Turbotax Online, developed the Innovation Catalyst program, and helped create the Design for Delight method that drives innovation at Intuit.

Tom Ulrich, Chief Scientist, Tandem Diabetes Care

Tom is one of the original employees of Tandem Diabetes Care and was responsible for all of the medical device software at Tandem for its first decade. In his current role as chief scientist, Tom was the technical lead for Tandem’s Control-IQ algorithm and leads Tandem’s Scientific Computing Group as they develop new dosing algorithms and metabolic models. Tom earned his PhD in organizational leadership at Regent University and has published and presented multiple articles on such topics as organizational culture, motivation to lead, followership, organizational wisdom, and leader emotion.